ALKemist Bio provides cell treatment to cancer patients.
ALKemist Bio has raised $7.6M in total funding. The most recent round was Seed. The last funding was announced in December 2023.
ALKemist Bio's investors include Claris Ventures, LIFTT.
ALKemist Bio is headquartered in Turin, Italy.
ALKemist Bio provides cell treatment to cancer patients.
ALKemist Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ALKemist Bio — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/alkemist-bio. Accessed August 17, 2026.
VCBacked. (2023). ALKemist Bio — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/alkemist-bio
{{cite web |title=ALKemist Bio — Funding & Investors |url=https://www.vcbacked.co/company/alkemist-bio |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated